Assignee
AXOLTIS PHARMA
FR·3 granted patents·4 pending applications·1 citations·filing 2016–2022
Top patents by PatentIndex Score
7 records- 0169US10501497B2Cyclic polypeptides, method for obtaining them and the therapeutic use thereofAXOLTIS PHARMA·Filed 2016·Granted Dec 10, 2019·1 cites·22 claims
- 0260US2025152660A1SCO-spondin-derived polypeptides for treating biological barriers dysfunctionAXOLTIS PHARMA·Filed 2022·Application pending·0 cites
- 0358US2025177481A1SCO-spondin-derived polypeptides for enhancing synaptic transmissionAXOLTIS PHARMA·Filed 2022·Application pending·0 cites
- 0446US12163154B2Use of peptide compounds for promoting survival, growth and cell differentiationAXOLTIS PHARMA·Filed 2017·Granted Dec 10, 2024·0 cites·2 claims
- 0543US2023212225A1Peptide compostions and methods for treating tauopathiesAXOLTIS PHARMA·Filed 2020·Application pending·0 cites
- 0642US2023073781A1Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelinationAXOLTIS PHARMA·Filed 2020·Application pending·0 cites
- 0731US11377471B2Process for the preparation of a dodecapeptideAXOLTIS PHARMA·Filed 2018·Granted Jul 5, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when AXOLTIS PHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →